Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 216.90
+0.65 (0.30%)
Nov 12, 2026, 3:30 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 14.33 billion as of November 12, 2026. It is the 22,232nd most valuable company in the world and the 1,439th biggest in India. Its market cap has increased by 1.59% in one year.
Market Cap
14.33B
Enterprise Value
13.30B
Revenue
3.16B
Global Rank
Country Rank
#1,439 India
PE Ratio
32.54
ChartMarket Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 14.33B, a decrease of -18.73%. That is a compound annual growth rate of -0.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 14.33B | 11.39% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 31.31B |
| Ind-Swift Laboratories | 30.52B |
| Sakar Healthcare | 22.85B |
| Indoco Remedies | 20.31B |
| Windlas Biotech | 20.06B |
| Beta Drugs | 19.07B |
| Anlon Healthcare | 14.31B |
| Bafna Pharmaceuticals | 11.18B |